Science Explorer Back to mapMap
Discussion
Researcher · Iranian Legal Medicine Organization · Iran

Mehrdad Setareh

Mehrdad Setareh publishes mostly in Epidemiology, Toxicology and Pulmonary and Respiratory Medicine, on topics such as Forensic Toxicology and Drug Analysis, Fungal Infections and Studies and Antifungal resistance and susceptibility.

OpenAlex
World rank
#6,540,139
of 7,710,434 ranked researchers
Rank in Iran
#56,445
of 71,317
Works
19
Citations
72
Citations per work
3.8
h-index
6
i10-index 2Top 82% in Epidemiology
Mehrdad Setareh

What does Mehrdad Setareh research?

Mehrdad Setareh's work is mostly in Medicine (29%), Pharmacology, Toxicology and Pharmaceutics (8%), Agricultural and Biological Sciences (4%).

Everything else: 10 works · 55.0% of their workHealth Sciences: 5 works · 28.6% of their workMedicine: 5 works · 28.6% of their workEpidemiology: 3 works · 14.3% of their workPulmonary and Respiratory Medicine: 2 works · 8.2% of their workInfectious Diseases: 1 works · 6.1% of their workLife Sciences: 3 works · 16.4% of their workPharmacology, Toxicology and Pharmaceutics: 2 works · 8.2% of their workToxicology: 2 works · 8.2% of their workAgricultural and Biological Sciences: 1 works · 4.1% of their workPlant Science: 1 works · 4.1% of their workBiochemistry, Genetics and Molecular Biology: 1 works · 4.1% of their workGenetics: 1 works · 4.1% of their workTHEIR WORKMehrdad Setareh19works
Life Sciences16%Health Sciences29%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else1055.0%
    1. Medicine528.6%
    1. Pharmacology, Toxicology and Pharmaceutics28.2%
    2. Agricultural and Biological Sciences14.1%
    3. Biochemistry, Genetics and Molecular Biology14.1%
  1. 1Epidemiology14% of their works
  2. 2Toxicology8% of their works
  3. 3Pulmonary and Respiratory Medicine8% of their works
  4. 4Infectious Diseases6% of their works
  5. 5Genetics4% of their works
  6. 6Plant Science4% of their works

Research topics

Which keywords describe Mehrdad Setareh's research?

The keywords of their largest research topics: Antifungal Therapy, Epidemiology, Immunocompromised Patients, Drug Analysis, Forensic Toxicology, Healthcare Quality, Candidiasis and Cryptococcal Disease.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 20 words, with their numbers
  1. Antifungal Therapy62 topics
  2. Epidemiology52 topics
  3. Immunocompromised Patients52 topics
  4. Drug Analysis41 topic
  5. Forensic Toxicology41 topic
  6. Healthcare Quality42 topics
  7. Candidiasis31 topic
  8. Cryptococcal Disease31 topic
  9. Histoplasmosis31 topic
  10. Invasive Fungal Infections31 topic
  11. Osteosarcoma31 topic
  12. Soft Tissue Sarcoma31 topic
  13. Alcohol Dependence21 topic
  14. Defensive Medicine21 topic
  15. Malpractice Risk21 topic
  16. Medical Errors21 topic
  17. Patient Safety Culture21 topic
  18. Pneumocystis21 topic
  19. Pneumonia21 topic
  20. Substance Use Disorders21 topic

Where does Mehrdad Setareh work?

Mehrdad Setareh's main affiliation in the publication record is Iranian Legal Medicine Organization, Iran.

How many publications and citations does Mehrdad Setareh have?

OpenAlex counts 19 works and 72 citations for Mehrdad Setareh, an h-index of 6, ranking #6,540,139 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Mehrdad Setareh. Posts are plain text and can be reported.